Bemotrizinol Could Change Sunscreen in the U.S.: What It Is and Why It Matters
For years, American shoppers have faced a frustrating sunscreen aisle: formulas that feel greasy, leave a white cast, or rely on older filters that are harder to formulate into elegant daily products. That may finally be changing, because the FDA has proposed adding bemotrizinol as a permitted active ingredient in sunscreens, and the ingredient could bring stronger UVA/UVB protection and better textures to the U.S. market.

What is bemotrizinol?
Bemotrizinol is a modern broad-spectrum UV filter used in many countries outside the U.S. for years. According to the FDA, it protects against both UVA and UVB rays, has low absorption through the skin, and rarely causes skin irritation.
That matters because UVA rays contribute to deeper skin damage and aging, while UVB rays are the main cause of sunburn. A sunscreen ingredient that covers both types well can make it easier for manufacturers to create daily-wear formulas people will actually use consistently.
Why U.S. sunscreen has lagged behind
The U.S. sunscreen market has been slow to adopt new active ingredients because sunscreens are regulated as over-the-counter drugs, and the approval process is demanding. The FDA has historically required extensive safety data for new ingredients, while many current U.S. filters have remained on the market without the same modern review standards expected of new actives.
That regulatory setup has helped create a long innovation gap. In practical terms, it means American consumers have had fewer ingredient options than shoppers in Europe and other regions where sunscreen filters are treated more like cosmetics.
Why bemotrizinol is different
Bemotrizinol stands out because it is photostable, broad-spectrum, and large enough to stay mostly on the skin’s surface rather than being significantly absorbed into the body, according to the FDA’s review. That combination makes it especially attractive to formulators looking for a filter that performs well without forcing a heavy or chalky texture.
For consumers, this could mean sunscreens that feel lighter, look better on skin tones, and are easier to wear every day. It may also reduce the need for multiple stabilizers and extra filters that can make formulas feel thicker or more irritating.
What the FDA proposal means
The FDA announced in November 2025 that it is proposing to add bemotrizinol to the sunscreen monograph, and the agency is now seeking public comments before issuing any final order. If finalized, bemotrizinol would become an additional sunscreen active ingredient recognized by the FDA as generally recognized as safe and effective for adults and children 6 months and older.
That does not mean every sunscreen on shelves will change overnight. Even if approval moves forward, brands still need time to reformulate, test, manufacture, and distribute new products.
How this affects sunscreen shoppers
The latest EWG guide, published in May 2026, reviewed 2,784 sunscreen products and found only 550 met the group’s criteria for safety and effectiveness. That reinforces a broader point: choosing sunscreen is still more complicated than it should be, especially for people who want something comfortable enough to use daily.
A better ingredient palette could improve that experience. If bemotrizinol reaches the U.S. market in finished products, shoppers may eventually see more elegant, non-greasy, broad-spectrum sunscreens with less white cast and fewer formulation compromises.
How to choose sunscreen now
Until new formulas reach stores, the best sunscreen is still the one you’ll wear consistently. The FDA says broad-spectrum SPF 15 or higher helps prevent sunburn and reduce the risks of skin cancer and early skin aging when used as directed with other sun-protective measures.
A few practical habits still matter:
- Apply enough to cover all exposed skin.
- Reapply about every two hours, and after swimming or sweating.
- Pair sunscreen with shade, hats, sunglasses, and protective clothing.
What happens next
The biggest near-term question is timing. The FDA has not yet finalized the proposal, but the move signals that U.S. sunscreen regulation may finally be opening the door to a modern filter that has been widely used abroad for years.
If approved, bemotrizinol could become the first meaningful step toward more advanced U.S. sunscreen options in decades. For consumers, that could mean better protection and better feel in the same bottle.
Sources
[1] FDA Proposes Expanding Sunscreen Active Ingredient List https://www.fda.gov/news-events/press-announcements/fda-proposes-expanding-sunscreen-active-ingredient-list
[2] Experts vet the safest and most effective sunscreens for 2026 https://www.cnn.com/2026/05/19/health/best-sunscreens-2026-wellness
[3] Bemotrizinol – SPF Manufacturers, Prepare Now https://certified-laboratories.com/blog/bemotrizinol-in-the-u-s-why-spf-product-manufacturers-should-prepare-now/
Schedule Your Consultation
Schedule a consultation at Longevity360 to explore the right treatment plan for you.














